Home » Stocks » ENDRA Life Sciences

ENDRA Life Sciences Inc. (NDRA)

Stock Price: $0.889 USD -0.020 (-2.24%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed
Pre-market: $0.880 -0.009 (-0.97%) Jul 10, 7:47 PM

Stock Price Chart

Key Info

Market Cap 12.89M
Revenue (ttm) n/a
Net Income (ttm) -18.10M
Shares Out 14.50M
EPS (ttm) -2.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 10, 2020
Last Price $0.889
Previous Close $0.909
Change ($) -0.020
Change (%) -2.24%
Day's Open 0.909
Day's Range 0.880 - 0.910
Day's Volume 189,960
52-Week Range 0.599 - 2.250

More Stats

Market Cap 12.89M
Enterprise Value 10.22M
Earnings Date (est) Aug 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 14.50M
Float 12.68M
EPS (basic) -2.26
EPS (diluted) -2.12
FCF / Share -0.80
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 559,618
Short Ratio 1.85
Short % of Float 4.50%
Beta 1.81
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 5.11
Revenue n/a
Operating Income -11.20M
Net Income -18.10M
Free Cash Flow -9.20M
Net Cash 2.67M
Net Cash / Share 0.18
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -154.90%
ROE -438.98%
ROIC 56,411.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$4.38*
(392.91% upside)
Low
2.75
Current: 0.889
High
6.00
Target: 4.38
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue-0.010.350.521.41
Revenue Growth--98.24%-31.8%-63.44%-
Gross Profit-0.010.180.280.74
Operating Income-10.84-9.02-5.38-2.77-1.57
Net Income-17.53-9.80-5.38-2.78-2.28
Shares Outstanding7.504.502.760.722.32
Earnings Per Share-2.34-2.17-1.95-3.84-0.98
Operating Cash Flow-8.59-7.70-3.30-1.32-0.84
Capital Expenditures-0.04-0.10-0.01--0.13
Free Cash Flow-8.63-7.80-3.31-1.32-0.98
Cash & Equivalents6.176.475.600.140.02
Total Debt0.71--0.95-
Net Cash / Debt5.476.475.60-0.810.02
Assets7.187.226.120.490.49
Liabilities2.420.970.851.380.24
Book Value4.766.255.28-0.890.25
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name ENDRA Life Sciences Inc.
Country United States
Employees 15
CEO Francois Michelon

Stock Information

Ticker Symbol NDRA
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: NDRA
IPO Date May 9, 2017

Description

ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. It also offers Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.